Metabolic Physiology Core
Metabolic Physiology Core
批准号:
7925277
负责人:
BARBARA B. KAHN
金额:
$35.15万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2015-03-31
关键词:
AddressAdipocytesAdipose tissueAnimal ModelAnimalsAreaArtsBiologicalBiological AssayBiopsyBody CompositionBody WeightBone DensityBostonCannulasCathetersCell NucleusConsultationsCoulter counterCustomDEXADataDevelopmentDiabetes MellitusDissectionDoctor of PhilosophyEatingEducational process of instructingEnergy MetabolismEquipmentExperimental DesignsFatty AcidsFatty acid glycerol estersFundingGenetically Engineered MouseGlucoseGlucose tolerance testGrantHomeostasisHormonesHumanHyperglycemiaHypoglycemiaHypothalamic structureIn VitroIndividualInfusion proceduresInjection of therapeutic agentInstitutesInsulinInsulin ResistanceInternationalIntravenousJournalsKnockout MiceLaboratoriesLeadLeptinLeptin resistanceLettersManuscriptsMeasurementMeasuresMetabolicMetabolismMethodsModelingMusNeuropeptidesNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsObesityOperative Surgical ProceduresPaperPeptidesPeripheralPhosphorylationPhysiologyPostdoctoral FellowPreparationProcessProductionProtocols documentationPublicationsPublishingPyruvatePyruvatesRattusResearchResearch DesignResearch PersonnelRodentRodent ModelRoleSTAT3 geneSamplingServicesSignal PathwaySignal TransductionSkeletal MuscleTechniquesTestingThinnessTimeTissue TransplantationTissuesTransgenic MiceTransgenic OrganismsTriglyceridesUnited States National Institutes of HealthVariantWorkWritingadenylate kinaseblood glucose regulationdesignenergy balanceexperiencefatty acid metabolismgene discoveryglucose productionglucose transportglucose uptakeimplantationin vitro Assayin vivoinsulin sensitivityinsulin sensitivity/resistanceinsulin signalinginsulin toleranceknockout genelipid biosynthesislipid metabolismmeetingsmembermetabolic abnormality assessmentmetabolomicsmouse modeloverexpressionresearch studyresponsesubcutaneoustool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Animal Metabolic Physiology Core is designed to meet the needs for characterization of rodent models that have alterations in glucose homeostasis, insulin action, leptin action and/or body composition. Its main function is to teach and provide consultation on ex vivo and in vivo methods to investigate the mechanisms for metabolic alterations in genetically-manipulated mouse models and in dietary models of obesity/leanness or insulin resistance/sensitivity.
The specific objectives of the Core are 1) to teach and 2) to provide consultation to investigators in designing, carrying out and interpreting in vitro and in vivo studies to investigate the action of insulin and hormones that regulate energy balance such as leptin; glucose homeostasis; lipid metabolism; and body composition; 3) The Core also performs a limited number of these studies on selected mouse or rat models created by or obtained by members of the Center.
Services of the Core include ex vivo methods such as adipocyte isolation, and dissection and incubation of isolated skeletal muscles to study glucose transport, insulin signaling, leptin signaling, and glucose and fatty acid metabolism. In vivo methods assessing insulin action and glucose homeostasis include insulin tolerance test, glucose tolerance test, signaling assays in response to insulin injection or infusion, and measurement of glucose turnover, endogenous glucose production and glucose uptake by individual tissues during clamp studies. In vivo methods to investigate biological actions of orexigenic and anorexigenic hormones include measurement of food intake, energy expenditure and leptin signaling in peripheral tissues and hypothalamic
nuclei. The Core also provides specialized equipment such as a DEXA scanner for non-invasive analysis of body composition and bone mineral density and a Coulter Counter for determining adipocyte number and size distribution. The Core Director, Barbara B. Kahn, MD, the Associate Core Director, Odile Peroni, PhD and the Research Associates who work with the Core have extensive experience with the metabolic and signaling assays offered by the Core. They are developing new assays to characterize additional aspects of integrated fuel metabolism and enerov homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Physiology and Energy Balance Core
-
批准号:10586204
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2023
-
负责人:BARBARA B. KAHN
-
依托单位:
Preclinical Studies of Novel Anti-Diabetic Lipids
-
批准号:9515379
-
项目类别:
-
资助金额:$90.31万
-
财政年份:2017
-
负责人:BARBARA B. KAHN
-
依托单位:
Mechanisms for regulation of a novel class of anti-diabetic lipids
-
批准号:10378154
-
项目类别:
-
资助金额:$76.03万
-
财政年份:2016
-
负责人:BARBARA B. KAHN
-
依托单位:
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
-
批准号:9895741
-
项目类别:
-
资助金额:$70.73万
-
财政年份:2016
-
负责人:BARBARA B. KAHN
-
依托单位:
Mechanisms for regulation of a novel class of anti-diabetic lipids
-
批准号:10609856
-
项目类别:
-
资助金额:$75.88万
-
财政年份:2016
-
负责人:BARBARA B. KAHN
-
依托单位:
Metabolic effects of adipose lipogenesis
-
批准号:8460669
-
项目类别:
-
资助金额:$63.58万
-
财政年份:2013
-
负责人:BARBARA B. KAHN
-
依托单位:
Metabolic effects of adipose lipogenesis
-
批准号:8626395
-
项目类别:
-
资助金额:$61.73万
-
财政年份:2013
-
负责人:BARBARA B. KAHN
-
依托单位:
Metabolic effects of adipose lipogenesis
-
批准号:8816092
-
项目类别:
-
资助金额:$61.73万
-
财政年份:2013
-
负责人:BARBARA B. KAHN
-
依托单位:
INTERPLAY OF TRANSTHYRETIN AND RETINOL BINDING PROTEIN IN TYPE 2 DIABETES
-
批准号:8365542
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2011
-
负责人:BARBARA B. KAHN
-
依托单位:
INTERPLAY OF TRANSTHYRETIN AND RETINOL BINDING PROTEIN IN TYPE 2 DIABETES
-
批准号:8170910
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2010
-
负责人:BARBARA B. KAHN
-
依托单位:
Glucose Transporter Regulation in Obesity and Diabetes
-
批准号:8006761
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:BARBARA B. KAHN
-
依托单位:
INTERPLAY OF TRANSTHYRETIN AND RETINOL BINDING PROTEIN IN TYPE 2 DIABETES
-
批准号:7955944
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2009
-
负责人:BARBARA B. KAHN
-
依托单位:
INTERPLAY OF TRANSTHYRETIN AND RETINOL BINDING PROTEIN IN TYPE 2 DIABETES
-
批准号:7723058
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2008
-
负责人:BARBARA B. KAHN
-
依托单位:
CENTRAL AND PERIPHERAL TARGETS FOR METABOLIC ACTIONS OF LEPTIN
-
批准号:7392811
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2007
-
负责人:BARBARA B. KAHN
-
依托单位:
Peripheral and Central Imteraction in Energy Balance
-
批准号:7500404
-
项目类别:
-
资助金额:$12.86万
-
财政年份:2007
-
负责人:BARBARA B. KAHN
-
依托单位:
INTERPLAY OF TRANSTHYRETIN AND RETINOL BINDING PROTEIN IN TYPE 2 DIABETES
-
批准号:7602052
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2007
-
负责人:BARBARA B. KAHN
-
依托单位:
CENTRAL AND PERIPHERAL TARGETS FOR METABOLIC ACTIONS OF LEPTIN
-
批准号:6928801
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2005
-
负责人:BARBARA B. KAHN
-
依托单位:
Administrative Core
-
批准号:6928804
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2005
-
负责人:BARBARA B. KAHN
-
依托单位:
FASEB Research Conf: Glucose Transporter Biology
-
批准号:6673276
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2003
-
负责人:BARBARA B. KAHN
-
依托单位:
Protein Tyrosine Phosphatase 1B and Insulin Action
-
批准号:6544727
-
项目类别:
-
资助金额:$48.28万
-
财政年份:2002
-
负责人:BARBARA B. KAHN
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: